JP2018507847A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507847A5
JP2018507847A5 JP2017541661A JP2017541661A JP2018507847A5 JP 2018507847 A5 JP2018507847 A5 JP 2018507847A5 JP 2017541661 A JP2017541661 A JP 2017541661A JP 2017541661 A JP2017541661 A JP 2017541661A JP 2018507847 A5 JP2018507847 A5 JP 2018507847A5
Authority
JP
Japan
Prior art keywords
use according
infection
agent
mmp1
pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541661A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507847A (ja
JP6783777B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2016/050156 external-priority patent/WO2016128975A1/en
Publication of JP2018507847A publication Critical patent/JP2018507847A/ja
Publication of JP2018507847A5 publication Critical patent/JP2018507847A5/ja
Application granted granted Critical
Publication of JP6783777B2 publication Critical patent/JP6783777B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541661A 2015-02-09 2016-02-09 二次感染の予防方法 Expired - Fee Related JP6783777B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562113551P 2015-02-09 2015-02-09
US62/113,551 2015-02-09
PCT/IL2016/050156 WO2016128975A1 (en) 2015-02-09 2016-02-09 Methods of preventing secondary infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020177658A Division JP7109515B2 (ja) 2015-02-09 2020-10-22 二次感染の予防方法

Publications (3)

Publication Number Publication Date
JP2018507847A JP2018507847A (ja) 2018-03-22
JP2018507847A5 true JP2018507847A5 (enExample) 2019-03-22
JP6783777B2 JP6783777B2 (ja) 2020-11-11

Family

ID=56615084

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017541661A Expired - Fee Related JP6783777B2 (ja) 2015-02-09 2016-02-09 二次感染の予防方法
JP2020177658A Expired - Fee Related JP7109515B2 (ja) 2015-02-09 2020-10-22 二次感染の予防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020177658A Expired - Fee Related JP7109515B2 (ja) 2015-02-09 2020-10-22 二次感染の予防方法

Country Status (7)

Country Link
US (2) US10610588B2 (enExample)
EP (1) EP3256135A4 (enExample)
JP (2) JP6783777B2 (enExample)
BR (1) BR112017017115A2 (enExample)
CA (1) CA2974925C (enExample)
HK (1) HK1244667A1 (enExample)
WO (1) WO2016128975A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2974925C (en) 2015-02-09 2022-03-22 Yeda Research And Development Co. Ltd. Methods of preventing secondary infections
USD841023S1 (en) * 2017-08-24 2019-02-19 Domo, Inc. Display screen or portion thereof with a graphical user interface
JP2023530997A (ja) * 2020-06-19 2023-07-20 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｂｓｔ２ロングアイソフォームを標的化する抗ｂｓｔ２抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
WO2004064728A2 (en) 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
EP1624866A2 (en) 2003-05-16 2006-02-15 Arriva Pharmaceuticals, Inc. Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
US7910620B2 (en) * 2005-04-22 2011-03-22 Broadhurst Iii Jack J Uses of neuraminidase inhibitors in infectious diseases
WO2015031654A2 (en) * 2013-08-28 2015-03-05 Cytonics Corporation Systems, compositions, and methods for transplantation and treating conditions
CA2974925C (en) 2015-02-09 2022-03-22 Yeda Research And Development Co. Ltd. Methods of preventing secondary infections

Similar Documents

Publication Publication Date Title
World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV)
CY1125329T1 (el) Αντιιικες ενωσεις πυραζολο- και τριαζολο-πυριμιδινης εναντι toy rsv
WO2016100807A3 (en) Human antibodies to influenza hemagglutinin
HRP20230274T1 (hr) Kemijski spojevi
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
CY1118774T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει εναν μη νουκλεοσιδικο αναστολεα αναστροφης μεταγραφασης
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
CY1124523T1 (el) Ν-[5-(αμινοσουλφονυλο)-4-μεθυλ-1,3-θειαζολ-2-υλ]-ν-μεθυλ-2-[4-(2-πυριδινυλ)-φαινυλ]-ημιενυδρη ελευθερη βαση ακεταμιδιου, μεθοδοι κατασκευης και χρησεις αυτης
JP2017537912A5 (enExample)
CN110062757A (zh) 凝血因子XIa抑制剂及其用途
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
Kasianenko et al. Nucleoside analogues for the treatment of influenza: history and experience
CL2018003390A1 (es) Beta-horquilla peptidomimética con actividad inhibidora de elastasa y formas de dosificación en aerosol de la misma.
JP2015516975A5 (enExample)
ES2555557R1 (es) Fármaco y uso para preparar un medicamento destinado a la prevención de la infección del VIH y al tratamiento de enfermedades causadas por el VIH, incluido el SIDA
BR112016007238A2 (pt) tienouracilcarboxamidas cíclicas e sua utilização
JP2006507295A5 (enExample)
BR112015028890A2 (pt) derivados de piridona para o tratamento de infecções virais e outras doenças
JP2013523789A5 (enExample)
WO2016180826A8 (en) Influenza virus neutralizing peptidomimetic compounds
JP2020530499A5 (enExample)
CN111565728A (zh) 含有亚铁氨基酸螯合物的组合物用于制造抑制血管新生的医药品的用途
BR112019002125A2 (pt) composição de comprimidos de alta carga de fármacos para o tratamento do hiv